At the Annual Meeting of the DPhG in Freiburg (Sept 29 – Oct 2, 2025), SHIELD coordinator Christian Klein co-chaired the session “Rethinking Antivirals” and introduced SHIELD 🛡️ to the audience.

Photo credits: Selina Muffler

#Antivirals #SHIELDproject #DPhG2025 #HorizonEurope

I’m reminded how important it is to stay open-minded: proximity-induced modalities are still new to me in antivirals, but already well established in oncology – which made the discussions especially rewarding.

#DPhG2025

As a molecular virologist, it’s humbling and inspiring to exchange ideas with experts in medicinal chemistry and drug development at the interface of chemistry and virology.

#DPhG2025

Today I had the chance to speak at the Annual Meeting of the German Pharmaceutical Society in Freiburg about targeted protein degradation as a novel paradigm in antiviral therapy.

#DPhG2025

Sept 29–Oct 2, Freiburg: Our coordinator Christian Klein will chair Rethinking Antivirals at #DPHG2025. Featuring Anna Hirsch (HIPS) on RSV F protein - showing SHIELD’s potential beyond our current targets.

📄 Program: meetinghand.com/e/dphg-jahre...

#SHIELDproject #Antivirals #RSV #Virology